A recent study has uncovered a dramatic 61-fold surge in methamphetamine-related deaths in the United States between 1999 and 2021, drawing attention to gender disparities and the growing impact of synthetic opioids. Researchers Andrew Yockey from the University of Mississippi and Rachel Hoopsick from the University of Illinois revealed that while men still account for higher mortality overall, female fatalities have risen at an even faster rate. During the study period, male deaths involving methamphetamine increased by a factor of 58.8, while female deaths rose by 65.3. This narrowing of the gender gap is linked not to falling male deaths but to an alarming acceleration in female mortality.
The crisis is further magnified by the rise of potent synthetic opioids such as fentanyl, which are commonly mixed with methamphetamine to lethal effect. Among men, cases involving both methamphetamine and synthetic opioids surged from 13.1% to 61.5%. These substances are more potent and easier to obtain, significantly contributing to the overall rise in fatalities. The COVID-19 pandemic has compounded the issue, limiting access to treatment and exacerbating mental health challenges, which coincided with a sharp rise in deaths from 2019 to 2021.
The researchers emphasise the need for a better understanding of gender-specific behaviours. Women generally achieve better outcomes in treatment, while men are less likely to seek help, providing an opportunity for more targeted intervention strategies. Looking ahead, Yockey, Hoopsick and their colleagues intend to explore the connection between methamphetamine use and suicide within rural regions of Mississippi. By collaborating with community groups, medical organisations, and local authorities, they aim to address local challenges and develop life-saving policies.
Source: News-medical.net
Leave a Reply